2m 2m 2m 2m 2m 2m 2m
Akebia Therapeut (AKBA)
NASDAQ
$1.38+$0.004 (+0.29%)
Price as of Jul 14, 2026 6:44 AM EDT- $370.2MMarket Cap
- -65.24%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Akebia Therapeut (AKBA)
$1.38+$0.004 (+0.29%)
Earnings Score
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -38.96% | ||
12-Month Momentum | -77.79% | ||
3-Month Risk Adjusted Momentum | -109.55% | ||
12-Month Risk Adjusted Momentum | -106.42% |
True Yield
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 1.88% |
Financial Health Score
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |